THE new BMW X3 was unveiled in London before it goes on sale in June.
The new model features expressive styling, new colors, and revisions to the interior design and trim options.
All models now feature more standard equipment, while customers can also choose a new xLine model to further personalize their X3.
Aside from its length, which has grown by a single centimeter, it has the same compact dimensions of its predecessor.
However, the new X3 features a host of design changes.
At the front end, new twin circular headlights — available in optional full LED specification along with optional LED front fog lamps — combined with the prominent BMW kidney grille and its new surround.
Both the front and rear bumpers have gained new contours, while the LED indicators are now housed in the new exterior mirrors.
Four new exterior paint shades and five new light-alloy wheel designs broaden the scope for individualization.
Inside, the new BMW X3 remains in top shape, with its carefully selected materials, understated chrome applications, a center console with optional automatic climate control system (with high-gloss black panel) and wood paneling with pearl chrome highlights.
New cup-holders, with a sliding cover, can be found in the center console, and a leather steering wheel is among the standard equipment.
Customers can also choose from four new upholstery colors and four new interior trims.
The new BMW X3 continues to lead its segment in terms of both interior spaciousness and rear load capacity, offering 550 liters with the seats up and 1,600 liters with the seats folded.
The X3 is available in xDrive as standard.
The intelligent xDrive all-wheel-drive system delivers optimum traction, with power sent where it is most needed, further improving on-road dynamics and driving safety.
New BMW X3 unveiled in Europe
New BMW X3 unveiled in Europe
Second doctor in Matthew Perry overdose case sentenced to home confinement
- Dr. Mark Chavez, 55, a onetime San Diego-based physician, pleaded guilty in federal court in October
- Judge Sherilyn Peace Garnett also sentenced Chavez to 300 hours of community service
LOS ANGELES: A second California doctor was sentenced on Tuesday to eight months of home confinement for illegally supplying “Friends” star Matthew Perry with ketamine, the powerful sedative that caused the actor’s fatal drug overdose in a hot tub in 2023.
Dr. Mark Chavez, 55, a onetime San Diego-based physician, pleaded guilty in federal court in October to a single felony count of conspiracy to distribute the prescription anesthetic and surrendered his medical license in November.
Judge Sherilyn Peace Garnett also sentenced Chavez to 300 hours of community service. As part of his plea agreement, Chavez admitted to selling ketamine to another physician Dr. Salvador Plasencia, 44, who in turn supplied the drug to Perry, though not the dose that ultimately killed the performer. Plasencia, who pleaded guilty to four counts of unlawful drug distribution, was sentenced earlier this month to 2 1/2 years behind bars.
He and Chavez were the first two of five people convicted in connection with Perry’s ketamine-induced death to be sent off to prison.
The three others scheduled to be sentenced in the coming weeks — Jasveen Sangha, 42, a drug dealer known as the “Ketamine Queen;” a go-between dealer Erik Fleming, 56; and Perry’s former personal assistant, Iwamasa, 60.
Sangha admitted to supplying the ketamine dose that killed Perry, and Iwamasa acknowledged injecting Perry with it. It was Iwamasa who later found Perry, aged 54, face down and lifeless, in the jacuzzi of his Los Angeles home on October 28, 2023.
An autopsy report concluded the actor died from the acute effects of ketamine,” which combined with other factors in causing him to lose consciousness and drown.
Perry had publicly acknowledged decades of substance abuse, including the years he starred as Chandler Bing on the hit 1990s NBC television series “Friends.”
According to federal law enforcement officials, Perry had been receiving ketamine infusions for treatment of depression and anxiety at a clinic where he became addicted to the drug.
When doctors there refused to increase his dosage, he turned to unscrupulous providers elsewhere willing to exploit Perry’s drug dependency as a way to make quick money, authorities said. Ketamine is a short-acting anesthetic with hallucinogenic properties that is sometimes prescribed to treat depression and other psychiatric disorders. It also has seen widespread abuse as an illicit party drug.
